RSNA: Reina Imaging showcases new DR panel products

TriMed Staff | | Health Imaging | Screening
Reina Imaging (Booth 4602) is presenting a new line of accessories for DR at the 2009 Radiological Society of North America (RSNA) conference in Chicago this month.

Recently added to the firm's Protect-A-Grid line is the PAG-DRP, a grid encasement for portable DR exams. According to the company, its drop-on styling allows snap on and off of any existing DR panel.

Reina said that facilities can transform an existing film-based x-ray space into a digital environment with its Trans-Former DRP mobile holder, using a wall bucky on wheels. The holder is custom made to interface with existing DR panels. No electrical outlet is required and the unit pivots from portrait to landscape.

TriMed Staff

Related Content

Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.